Bioidentical Hormone Replacement Therapy in San Diego: What It Is, Who It's For, and What to Expect

Written for San Diego Naturopathic. Clinically reviewed by Dr. Peter Wannigman, ND. Last reviewed: August 24, 2026.

If you have spent the last two years feeling like a slightly worse version of yourself, you have probably already had the conversation where someone told you it was stress, or sleep, or just your age.

Sleep that used to be automatic now takes work. Your temperature regulation is unpredictable. Your mood has a shorter fuse, and you notice it most with the people you least want to snap at. You brought it up, you got a basic panel, and you were told everything looked fine.

That experience is why most people start reading about bioidentical hormone replacement therapy in San Diego in the first place. Not because they want a dramatic intervention, but because they want someone to actually look.

What follows is a plain explanation of what bioidentical hormone replacement therapy is, how a clinician decides whether someone is a reasonable candidate, what intake and monitoring involve, and what to ask any provider before you begin. It is deliberately not a pitch. Hormone therapy is a real medical decision with real tradeoffs, and the honest version of this conversation is more useful to you than an enthusiastic one.

What is bioidentical hormone therapy?

"Bioidentical" describes the molecule, not the source and not the brand.

A bioidentical hormone is one that is structurally identical to a hormone your own body produces. The main ones used clinically are 17-beta estradiol, progesterone, testosterone, and DHEA. They are manufactured, usually from plant precursors such as soy or yam, then processed until the finished molecule matches the human one.

That is worth saying clearly, because "bioidentical" gets used loosely in marketing. It does not mean natural in the sense of unprocessed, it does not mean plant products you can buy without a prescription, and it is not an FDA regulatory category. It describes molecular structure, nothing more.

What follows from that structure is real but modest: because the molecule is one your receptors already recognize, its behavior in the body is the behavior of the native hormone. That is a meaningful pharmacologic point. It is not, by itself, a safety guarantee.

BHRT vs conventional HRT: the difference that actually matters

This is where most online explanations go sideways, so here is the more accurate version.

Some bioidentical hormones are FDA-approved. Estradiol patches, gels, sprays, and tablets are FDA-approved. Oral micronized progesterone is FDA-approved. There are FDA-approved combination products containing both. These are bioidentical, and they are also standardized, dose-verified, and carry required safety labeling.

Some bioidentical hormones are compounded. Compounded preparations are custom-mixed by a compounding pharmacy, often in combinations or strengths no approved product offers. They are not FDA-approved, meaning they have not gone through review for potency consistency, purity, or labeling. A 2020 review by the National Academies of Sciences, Engineering, and Medicine examined compounded hormone therapy specifically, concluded the evidence did not support its broad routine use over approved products, and recommended reserving it for cases with a documented clinical reason, such as an allergy to an ingredient in an approved product.

Conventional hormone therapy is often shorthand for older formulations, including conjugated equine estrogens and synthetic progestins, which are not structurally identical to human hormones. Much of the best known long-term risk data comes from studies of those formulations.

So the useful framing is not "bioidentical good, conventional bad." It is that there are real differences between hormone molecules, and real differences between FDA-approved and compounded preparations, and those are two separate questions marketing frequently blurs into one. A provider who can explain both distinctions clearly is a better sign than one who leads with the word "natural."

Who bioidentical hormones are typically considered for

Hormone therapy is not a general wellness upgrade, and it is not appropriate for everyone. The people it is most commonly evaluated for are:

• Women in perimenopause and menopause. The largest group, and where the "bioidentical hormones for women over 40" search usually starts. Perimenopause can begin years before periods stop, and the hormonal variability in that window is often more disruptive than the steadier state that eventually follows.
• Women with early or surgically induced menopause. When ovarian function ends well before the average age, the clinical conversation is different and generally more proactive.
• Men with clinically confirmed low testosterone. Confirmed being the operative word: this requires repeated morning serum testing, not a single reading, and an evaluation of why levels are low before deciding whether to treat.
• People with a documented endocrine issue identified through appropriate workup, where hormone support is one part of a broader plan.

Equally important is who it is generally not appropriate for. Standard contraindications and cautions include a personal history of breast cancer or other hormone-sensitive cancer, a history of blood clots, stroke, or heart attack, unexplained vaginal bleeding that has not been worked up, active liver disease, and pregnancy. Family history, cardiovascular risk, and how far you are from your final period all factor in as well, and evidence generally suggests a more favorable risk profile when systemic therapy begins closer to the menopausal transition rather than many years after.

None of that can be determined from an article. It is the actual substance of the evaluation.

How candidacy gets evaluated: the intake

A responsible hormone workup is slower than most people expect, and that pace is the point.

A full history first

Symptom pattern and timeline, menstrual and reproductive history, surgical history, current medications and supplements, personal and family cancer history, cardiovascular and clotting history, sleep, stress load, and what has already been tried. Much of what looks hormonal overlaps with thyroid conditions, iron deficiency, sleep apnea, and mood disorders, and those need to be on the table rather than assumed away.

Baseline laboratory testing

Which markers get ordered depends on your presentation, your sex, and where you are in the menopausal transition, but a baseline workup typically extends beyond sex hormones alone to include thyroid function and other markers that produce overlapping symptoms.

A conversation about testing method

Serum testing is the standard basis for clinical decisions in most guidelines. Saliva and dried urine testing are used in some practices. If a provider uses something other than serum, it is reasonable to ask why, and how the result changes their decision.

A documented risk and benefit discussion

A two-way conversation about your specific risk profile, not a form you sign.

Coordination with your existing care team

If you have a primary care physician, an OB-GYN, an endocrinologist, or a cardiologist, they should know. Hormone therapy sits alongside the rest of your care, not outside it. Records should move in both directions, and no one should be asking you to change, reduce, or stop a medication another clinician prescribed. If that comes up anywhere, it is a conversation for the prescriber.

You can read more about how these evaluations are structured on the Hormone Imbalances page.

What monitoring looks like after you start

If you and a clinician decide to proceed, the work is not finished at the prescription. Ongoing management generally includes:

• A follow-up in the first few months. Repeat labs and a symptom review are commonly done around eight to twelve weeks after starting or after any dose change, since that is roughly how long levels and response take to stabilize.
• Dose adjustment based on the whole picture. How you are doing and what the labs show, not one in isolation.
• The lowest effective dose, reviewed over time. Duration of therapy is meant to be revisited, not set once and forgotten.
• Continued age-appropriate screening. Mammography, pelvic exams, blood pressure, lipids, and prostate screening for men continue on their normal schedules.
• A standing plan for what to report immediately. New chest pain, shortness of breath, leg swelling or pain, severe headache, visual changes, or unexpected vaginal bleeding warrant prompt evaluation rather than waiting for the next appointment.

If a practice cannot tell you its monitoring schedule before you start, that is useful information.

Questions worth asking any BHRT provider

Bring these to any consultation, here or anywhere else:

1. FDA-approved product or compounded, and what is the clinical reason for that choice?
2. If compounded, which pharmacy, and is it licensed and inspected?
3. Which delivery form, and why that one over the alternatives? (Ask about pellets specifically, since dosing cannot be adjusted downward once they are placed.)
4. What testing is this based on, and will you repeat it?
5. What is the follow-up schedule, and what does it cost?
6. Given my personal and family history, what are my specific risks?
7. How will you communicate with my other physicians?
8. What would make you recommend stopping or changing course?
9. Do you sell the products you prescribe, and how does that work?

A provider who welcomes those questions is telling you something. So is one who does not.

Bioidentical hormone replacement therapy in San Diego: the local picture

San Diego has an unusually wide range of places offering hormone therapy, and they are not equivalent. Searches for bioidentical hormone replacement therapy in San Diego return med spas, longevity clinics, telehealth prescribers, OB-GYN practices, endocrinology groups, and naturopathic practices, all using overlapping language. The models behind them differ substantially in intake depth, follow-up structure, and how much of the visit is spent on evaluation versus enrollment. Sorting that out is harder here than in a smaller market, which is why the questions above matter more locally than you might expect.

The population is the other local factor. San Diego skews toward active adults who stay physically capable into their fifties and sixties, with a large military and veteran community and a high proportion of people who track their own health data closely. In practice a lot of people here notice hormonal changes earlier and more precisely, because the change shows up against a baseline they were already watching: training that stopped producing results, recovery that takes longer, sleep quality they can point to on a chart.

For patients coming to the Mission Valley area, the practical advantage is the geographic center of the county. The Camino del Rio corridor sits where I-8, I-805, and SR-163 converge, within a reasonable drive of La Jolla, North Park, Hillcrest, Clairemont, Coronado, Poway, and the South Bay. For a therapy that involves an initial visit plus scheduled follow-ups over several months rather than a single appointment, drive time is a legitimate factor in whether people actually complete the monitoring plan.

What a first conversation looks like

A discovery call is a short, no-pressure conversation about what you have been experiencing, what has already been investigated, and whether a hormone workup is a sensible next step. Sometimes the answer is that a different evaluation should come first. That is a real possible outcome and a fine one.

If you want to understand the approach and the clinician before committing to anything, the About page covers background and credentials, and the Bioidentical Hormone Replenishment Therapy service page covers how the service is structured.

Schedule a discovery call when you are ready to talk it through.

Frequently Asked Questions

This article is general health education, not medical advice, and reading it does not create a patient relationship. Hormone therapy is not appropriate for everyone and carries risks that should be evaluated individually with a qualified clinician. Do not start, stop, or change any prescribed medication or treatment without speaking with the clinician who prescribed it.